HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan
Abstract
Authors
K Morimoto K Moriwaki K Shimozuma T Nakayama
K Morimoto K Moriwaki K Shimozuma T Nakayama
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now